Burning Rock Biotech (BNR) Competitors $4.52 -0.18 (-3.83%) Closing price 03/28/2025 03:58 PM EasternExtended Trading$4.57 +0.05 (+1.11%) As of 03/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. AIRS, SERA, BDSX, QIPT, CORBF, EUDA, TOI, XGN, PIII, and ENZShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include AirSculpt Technologies (AIRS), Sera Prognostics (SERA), Biodesix (BDSX), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), EUDA Health (EUDA), Oncology Institute (TOI), Exagen (XGN), P3 Health Partners (PIII), and Enzo Biochem (ENZ). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. AirSculpt Technologies Sera Prognostics Biodesix Quipt Home Medical Global Cord Blood EUDA Health Oncology Institute Exagen P3 Health Partners Enzo Biochem AirSculpt Technologies (NASDAQ:AIRS) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and community ranking. Which has higher valuation and earnings, AIRS or BNR? AirSculpt Technologies has higher earnings, but lower revenue than Burning Rock Biotech. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAirSculpt Technologies$180.35M0.74-$4.48M-$0.15-15.27Burning Rock Biotech$510.89M0.09-$92.07M-$3.00-1.51 Does the media favor AIRS or BNR? In the previous week, Burning Rock Biotech had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 5 mentions for Burning Rock Biotech and 2 mentions for AirSculpt Technologies. Burning Rock Biotech's average media sentiment score of 0.31 beat AirSculpt Technologies' score of -0.28 indicating that Burning Rock Biotech is being referred to more favorably in the news media. Company Overall Sentiment AirSculpt Technologies Neutral Burning Rock Biotech Neutral Which has more risk & volatility, AIRS or BNR? AirSculpt Technologies has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Does the MarketBeat Community believe in AIRS or BNR? AirSculpt Technologies received 6 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 36.67% of users gave AirSculpt Technologies an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote. CompanyUnderperformOutperformAirSculpt TechnologiesOutperform Votes1136.67% Underperform Votes1963.33% Burning Rock BiotechOutperform Votes531.25% Underperform Votes1168.75% Do analysts recommend AIRS or BNR? AirSculpt Technologies presently has a consensus price target of $5.00, indicating a potential upside of 118.34%. Given AirSculpt Technologies' stronger consensus rating and higher probable upside, analysts clearly believe AirSculpt Technologies is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AirSculpt Technologies 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in AIRS or BNR? 91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 78.8% of AirSculpt Technologies shares are owned by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is AIRS or BNR more profitable? AirSculpt Technologies has a net margin of -4.13% compared to Burning Rock Biotech's net margin of -83.50%. AirSculpt Technologies' return on equity of 2.22% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets AirSculpt Technologies-4.13% 2.22% 0.90% Burning Rock Biotech -83.50%-60.68%-42.30% SummaryAirSculpt Technologies beats Burning Rock Biotech on 13 of the 17 factors compared between the two stocks. Remove Ads Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ ExchangeMarket Cap$46.30M$2.83B$7.13B$7.83BDividend YieldN/A22.57%2.53%4.01%P/E Ratio-1.5113.1729.8118.70Price / Sales0.09202.00151.6590.67Price / CashN/A57.5631.4034.64Price / Book0.434.354.764.23Net Income-$92.07M-$22.21M$195.05M$247.15M7 Day Performance-17.82%51.05%-1.40%-2.18%1 Month Performance-27.51%12.95%-5.16%-5.68%1 Year Performance-37.92%-3.70%2.29%-0.74% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.7619 of 5 stars$4.52-3.8%N/A-37.9%$46.30M$510.89M-1.511,390Earnings ReportAIRSAirSculpt Technologies1.2687 of 5 stars$2.74+3.4%$5.00+82.5%-62.7%$160.50M$180.35M-19.57240Short Interest ↑High Trading VolumeSERASera Prognostics0.6612 of 5 stars$4.14+9.2%N/A-61.1%$139.82M$77,000.00-4.18120Positive NewsBDSXBiodesix2.8679 of 5 stars$0.83-1.9%$2.95+255.2%-53.1%$121.24M$71.32M-2.13220Short Interest ↑Positive NewsGap DownQIPTQuipt Home Medical2.635 of 5 stars$2.34-1.3%$6.25+167.1%-46.9%$100.83M$244.72M-13.76800CORBFGlobal Cord BloodN/A$0.80flatN/A-40.7%$97.24M$196.12M0.001,200Gap DownEUDAEUDA Health0.4365 of 5 stars$3.93-3.2%N/A+100.0%$96.79M$3.81M0.002TOIOncology Institute0.3439 of 5 stars$1.24+24.5%N/A-27.8%$93.69M$378.93M-1.59660Earnings ReportNews CoverageHigh Trading VolumeXGNExagen4.6678 of 5 stars$4.05+4.4%$7.50+85.2%+141.5%$72.49M$55.64M-4.31220Short Interest ↓Positive NewsPIIIP3 Health Partners1.965 of 5 stars$0.19+8.4%$0.25+34.1%-83.3%$66.88M$1.48B-0.22500Earnings ReportShort Interest ↑News CoverageENZEnzo Biochem0.5314 of 5 stars$0.49+0.8%N/A-66.1%$25.68M$29.09M0.00520News CoverageGap Down Remove Ads Related Companies and Tools Related Companies AirSculpt Technologies Competitors Sera Prognostics Competitors Biodesix Competitors Quipt Home Medical Competitors Global Cord Blood Competitors EUDA Health Competitors Oncology Institute Competitors Exagen Competitors P3 Health Partners Competitors Enzo Biochem Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
